A Long Term Safety Study of BCX7353 in Hereditary Angioedema
Trial details
- Registry ID
- NCT03472040
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Long Term Safety Study of BCX7353 in Hereditary AngioedemaNCT03472040 | BioCryst Pharmaceuticals | Phase 2, Phase 3 | Completed | 2022-04-27Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |